• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎的时空流行病学荟萃分析。

A meta-analysis of the epidemiology of giant cell arteritis across time and space.

机构信息

Schulich School of Medicine, University of Western Ontario, St. Joseph's Health Care, 268 Grosvenor St, D2 Rheumatology, London, ON, N6A 4V2, Canada.

University College Dublin, School of Medicine and Medical Sciences, Dublin 4, Ireland.

出版信息

Arthritis Res Ther. 2021 Mar 11;23(1):82. doi: 10.1186/s13075-021-02450-w.

DOI:10.1186/s13075-021-02450-w
PMID:33706808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7948334/
Abstract

INTRODUCTION

Giant cell arteritis (GCA) is a common large vessel vasculitis in those over age 50 years. This meta-analysis examined the geographical and temporal distribution of the incidence, prevalence, and mortality of GCA.

METHODS

A systematic review was conducted using EMBASE, Scopus, and PubMed from their inceptions until 2019. Studies were included if they reported at least 50 or more GCA patients and defined the location and time frame. Articles on mortality were included and standardized mortality ratio (SMR) was extracted where possible. Mean pooled prevalence, incidence, and SMR were calculated using a random effects model. Linear regression was used to explore correlations between latitude and incidence, prevalence, and mortality.

RESULTS

Of the 3569 citations identified, 107 were included. The pooled incidence of GCA was 10.00 [9.22, 10.78] cases per 100,000 people over 50 years old. This incidence was highest in Scandinavia 21.57 [18.90, 24.23], followed by North and South America 10.89 [8.78, 13.00], Europe 7.26 [6.05, 8.47], and Oceania 7.85 [- 1.48, 17.19]. Pooled prevalence was 51.74 [42.04, 61.43] cases per 100,000 people over age 50. Annual mortality was 20.44 [17.84, 23.03] deaths/1000. Mortality generally decreased over the years of publication (p = 0.0008). Latitude correlated significantly with incidence (p = 0.0011), but not with prevalence, or mortality.

CONCLUSIONS

GCA incidence varies nearly 3-fold between regions and is highest in Scandinavia but not significantly. Mortality may be improving over time.

摘要

简介

巨细胞动脉炎(GCA)是一种常见的大血管血管炎,主要发生于 50 岁以上人群。本荟萃分析旨在探讨 GCA 的发病率、患病率和死亡率的地域和时间分布。

方法

通过 EMBASE、Scopus 和 PubMed 系统检索自建库至 2019 年的文献,纳入至少报告 50 例以上 GCA 患者且明确地理位置和时间范围的研究。纳入报道死亡率的文章,并尽可能提取标准化死亡率比(SMR)。采用随机效应模型计算平均合并患病率、发病率和 SMR。采用线性回归分析探讨纬度与发病率、患病率和死亡率之间的相关性。

结果

共纳入 3569 篇文献,其中 107 篇符合纳入标准。50 岁以上人群中 GCA 的发病率为 10.00[9.22,10.78]例/10 万人。发病率最高的地区为斯堪的纳维亚(21.57[18.90,24.23]),其次为北美和南美(10.89[8.78,13.00])、欧洲(7.26[6.05,8.47])和大洋洲(7.85[-1.48,17.19])。50 岁以上人群中 GCA 的患病率为 51.74[42.04,61.43]例/10 万人。年死亡率为 20.44[17.84,23.03]例/1000 人。死亡率随发表年份的增加而逐渐下降(p=0.0008)。纬度与发病率显著相关(p=0.0011),但与患病率和死亡率无显著相关性。

结论

GCA 的发病率在不同地区差异近 3 倍,斯堪的纳维亚地区发病率最高,但无统计学差异。死亡率可能随时间推移而逐渐降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/3d842194a9c0/13075_2021_2450_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/9496eb297783/13075_2021_2450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/2a0d115ef368/13075_2021_2450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/f64a76ff1eec/13075_2021_2450_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/0e68f7ee957e/13075_2021_2450_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/3d842194a9c0/13075_2021_2450_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/9496eb297783/13075_2021_2450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/2a0d115ef368/13075_2021_2450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/f64a76ff1eec/13075_2021_2450_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/0e68f7ee957e/13075_2021_2450_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2131/7948334/3d842194a9c0/13075_2021_2450_Fig5_HTML.jpg

相似文献

1
A meta-analysis of the epidemiology of giant cell arteritis across time and space.巨细胞动脉炎的时空流行病学荟萃分析。
Arthritis Res Ther. 2021 Mar 11;23(1):82. doi: 10.1186/s13075-021-02450-w.
2
Epidemiology of large vasculitis in Shanghai, China: A 10-year multicenter hospital-based study and systematic review.中国上海大血管炎的流行病学:一项为期 10 年的多中心基于医院的研究和系统评价。
Int J Rheum Dis. 2024 Oct;27(10):e15360. doi: 10.1111/1756-185X.15360.
3
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.意大利北部大血管血管炎(巨细胞动脉炎和 Takayasu 动脉炎)的发病率和患病率:一项基于人群的研究。
Semin Arthritis Rheum. 2021 Aug;51(4):786-792. doi: 10.1016/j.semarthrit.2021.06.001. Epub 2021 Jun 7.
4
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.西班牙西北部经活检证实的巨细胞动脉炎的流行病学:18年期间的趋势
Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367.
5
Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.1972-2012 年挪威西部巨细胞动脉炎的发病率:一项回顾性队列研究。
Arthritis Res Ther. 2017 Dec 15;19(1):278. doi: 10.1186/s13075-017-1479-6.
6
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.巨细胞动脉炎和风湿性多肌痛的发病率和患病率:系统文献回顾。
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048. doi: 10.1016/j.semarthrit.2020.07.005. Epub 2020 Jul 14.
7
Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.新西兰怀卡托地区巨细胞动脉炎的流行病学。
N Z Med J. 2024 Mar 22;137(1592):14-21. doi: 10.26635/6965.6379.
8
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.巨细胞动脉炎中大动脉受累:一项基于人群的发病趋势和预后的队列研究。
Ann Rheum Dis. 2013 Dec;72(12):1989-94. doi: 10.1136/annrheumdis-2012-202408. Epub 2012 Dec 19.
9
Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.巨细胞动脉炎患者患糖尿病的患病率较低:一项系统评价和荟萃分析。
Mod Rheumatol. 2016;26(3):410-4. doi: 10.3109/14397595.2015.1081722. Epub 2015 Sep 18.
10
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.HLA-DRB1氨基酸残基与巨细胞动脉炎的关联:遗传关联研究、荟萃分析及地理流行病学调查
Arthritis Res Ther. 2015 Jul 30;17(1):195. doi: 10.1186/s13075-015-0692-4.

引用本文的文献

1
Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Polymyalgia Rheumatica Presenting with Double Vision.一名患有风湿性多肌痛且出现复视的患者发生甲氨蝶呤相关淋巴增殖性疾病。
Neuroophthalmology. 2024 Jun 17;49(1):75-82. doi: 10.1080/01658107.2024.2365262. eCollection 2025.
2
Approach to Eye Pain: Differential Diagnosis and Work Up for the Neurologist.眼部疼痛的诊疗方法:神经科医生的鉴别诊断与检查
Curr Neurol Neurosci Rep. 2025 Jul 12;25(1):48. doi: 10.1007/s11910-025-01436-4.
3
Illness Burden and Unmet Patient Needs in Giant Cell Arteritis: Current State and Future Prospects.

本文引用的文献

1
Incidence and prevalence of giant cell arteritis in Ontario, Canada.加拿大安大略省巨细胞动脉炎的发病率和患病率。
Rheumatology (Oxford). 2020 Nov 1;59(11):3250-3258. doi: 10.1093/rheumatology/keaa095.
2
Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study.巨细胞动脉炎患者的死亡率:一项基于大规模人群的队列研究。
J Rheumatol. 2020 Sep 1;47(9):1385-1391. doi: 10.3899/jrheum.190927. Epub 2019 Dec 15.
3
Giant cell arteritis: early diagnosis is key.巨细胞动脉炎:早期诊断是关键。
巨细胞动脉炎的疾病负担与未满足的患者需求:现状与未来展望
Open Access Rheumatol. 2025 Jul 1;17:117-134. doi: 10.2147/OARRR.S517664. eCollection 2025.
4
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies.细胞因子导向疗法治疗VEXAS综合征的疾病轨迹与糖皮质激素暴露情况
Ann Rheum Dis. 2025 Jun 27. doi: 10.1016/j.ard.2025.05.021.
5
Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation.2010年至2020年芬兰的巨细胞动脉炎:发病率、诊断方法的发展及疾病表现
Rheumatol Adv Pract. 2025 May 15;9(2):rkaf055. doi: 10.1093/rap/rkaf055. eCollection 2025.
6
The mortality and acute complications of large vessel vasculitis patients hospitalized with COVID-19 in the US: a nationwide inpatient sample analysis (2020).美国新冠肺炎住院大血管血管炎患者的死亡率和急性并发症:一项全国住院患者样本分析(2020年)
Rheumatol Int. 2025 Feb 22;45(3):59. doi: 10.1007/s00296-025-05811-9.
7
Utilising multiple discharge coding will improve identification of patients with giant cell arteritis: a retrospective analysis of a hospital discharge dataset.使用多重出院编码将改善巨细胞动脉炎患者的识别:一项医院出院数据集的回顾性分析
Rheumatol Int. 2025 Feb 21;45(3):58. doi: 10.1007/s00296-025-05814-6.
8
Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska.阿拉斯加原住民和阿拉斯加印第安人的血管炎患病率及临床特征
Arthritis Care Res (Hoboken). 2025 Jul;77(7):873-880. doi: 10.1002/acr.25506. Epub 2025 Mar 5.
9
Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review.影响巨细胞动脉炎脑血管缺血事件的危险因素及药物干预:一项叙述性综述
Immun Inflamm Dis. 2025 Jan;13(1):e70122. doi: 10.1002/iid3.70122.
10
Clinical, laboratory, and orbital imaging features of giant cell arteritis in comparison to non-arteritic anterior ischemic optic neuropath: a single center case series.巨细胞动脉炎与非动脉炎性前部缺血性视神经病变的临床、实验室及眼眶影像学特征比较:一项单中心病例系列研究
Front Ophthalmol (Lausanne). 2024 Dec 24;4:1498968. doi: 10.3389/fopht.2024.1498968. eCollection 2024.
Eye Brain. 2019 Jan 17;11:1-12. doi: 10.2147/EB.S170388. eCollection 2019.
4
Increased Incidence of Giant Cell Arteritis in Urban Areas?城市地区巨细胞动脉炎发病率增加?
J Rheumatol. 2019 Mar;46(3):327-328. doi: 10.3899/jrheum.180714. Epub 2019 Jan 15.
5
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.HLA-DRB1氨基酸残基与巨细胞动脉炎的关联:遗传关联研究、荟萃分析及地理流行病学调查
Arthritis Res Ther. 2015 Jul 30;17(1):195. doi: 10.1186/s13075-015-0692-4.
6
Immune mechanisms in medium and large-vessel vasculitis.中等和大血管血管炎的免疫机制。
Nat Rev Rheumatol. 2013 Dec;9(12):731-40. doi: 10.1038/nrrheum.2013.161. Epub 2013 Nov 5.
7
Optimal management of giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛的最佳治疗管理。
Ther Clin Risk Manag. 2012;8:173-9. doi: 10.2147/TCRM.S13088. Epub 2012 Apr 5.
8
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis.白细胞介素 18 基因多态性与活检证实的巨细胞动脉炎的相关性。
Arthritis Res Ther. 2010;12(2):R51. doi: 10.1186/ar2962. Epub 2010 Mar 23.
9
Increase in age at onset of giant cell arteritis: a population-based study.巨细胞动脉炎发病年龄的增加:一项基于人群的研究。
Ann Rheum Dis. 2010 Apr;69(4):780-1. doi: 10.1136/ard.2009.111005. Epub 2009 Oct 22.
10
Vascular damage in giant cell arteritis.巨细胞动脉炎中的血管损伤。
Autoimmunity. 2009 Nov;42(7):596-604. doi: 10.1080/08916930903002495.